Bigelow Investment Advisors LLC lowered its stake in UnitedHealth Group Inc (NYSE:UNH) by 12.3% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 4,512 shares of the healthcare conglomerate’s stock after selling 631 shares during the period. Bigelow Investment Advisors LLC’s holdings in UnitedHealth Group were worth $1,116,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc lifted its position in UnitedHealth Group by 1.6% in the third quarter. Vanguard Group Inc now owns 69,342,549 shares of the healthcare conglomerate’s stock worth $18,447,892,000 after purchasing an additional 1,073,505 shares during the period. Evolution Wealth Advisors LLC acquired a new stake in UnitedHealth Group in the fourth quarter worth approximately $76,000. Advisor Partners LLC lifted its position in UnitedHealth Group by 6.5% in the fourth quarter. Advisor Partners LLC now owns 31,893 shares of the healthcare conglomerate’s stock worth $7,945,000 after purchasing an additional 1,949 shares during the period. Allen Capital Group LLC lifted its position in UnitedHealth Group by 5.3% in the fourth quarter. Allen Capital Group LLC now owns 4,525 shares of the healthcare conglomerate’s stock worth $1,201,000 after purchasing an additional 226 shares during the period. Finally, Crescent Grove Advisors LLC acquired a new stake in UnitedHealth Group in the fourth quarter worth approximately $373,000. 85.74% of the stock is currently owned by institutional investors.
UNH has been the subject of a number of research analyst reports. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, March 19th. Bank of America restated a “buy” rating and issued a $290.00 target price (down from $320.00) on shares of UnitedHealth Group in a research report on Wednesday, April 17th. Raymond James cut their target price on UnitedHealth Group from $310.00 to $265.00 and set a “strong-buy” rating for the company in a research report on Wednesday, April 17th. ValuEngine downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday, February 27th. Finally, Citigroup upgraded UnitedHealth Group from a “neutral” rating to a “buy” rating and upped their target price for the stock from $247.00 to $280.00 in a research report on Friday, May 10th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, eighteen have issued a buy rating and one has given a strong buy rating to the company. The company presently has an average rating of “Buy” and an average price target of $290.84.
Shares of NYSE:UNH opened at $244.50 on Thursday. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.73 and a current ratio of 0.73. UnitedHealth Group Inc has a 12-month low of $208.07 and a 12-month high of $287.94. The firm has a market cap of $234.52 billion, a price-to-earnings ratio of 18.98, a PEG ratio of 1.32 and a beta of 0.65.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $3.73 EPS for the quarter, beating the consensus estimate of $3.60 by $0.13. UnitedHealth Group had a net margin of 5.45% and a return on equity of 25.07%. The business had revenue of $60.30 billion for the quarter, compared to analysts’ expectations of $59.72 billion. During the same period in the previous year, the company posted $3.04 EPS. UnitedHealth Group’s revenue was up 9.2% on a year-over-year basis. On average, sell-side analysts forecast that UnitedHealth Group Inc will post 14.71 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 25th. Stockholders of record on Monday, June 17th will be issued a dividend of $1.08 per share. This is a boost from UnitedHealth Group’s previous quarterly dividend of $0.90. This represents a $4.32 annualized dividend and a dividend yield of 1.77%. The ex-dividend date is Friday, June 14th. UnitedHealth Group’s payout ratio is currently 27.95%.
COPYRIGHT VIOLATION NOTICE: “Bigelow Investment Advisors LLC Reduces Holdings in UnitedHealth Group Inc (NYSE:UNH)” was first reported by Ticker Report and is the property of of Ticker Report. If you are reading this piece on another website, it was stolen and reposted in violation of U.S. & international copyright and trademark law. The correct version of this piece can be read at https://www.tickerreport.com/banking-finance/4369910/bigelow-investment-advisors-llc-reduces-holdings-in-unitedhealth-group-inc-nyseunh.html.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.